Bellamy, MF, McDowell, IFW, Ramsey, MW, Brownlee, M, Bones, C, Newcombe, RG & Lewis, MJ (1998) Hyperho-mocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults. Circulation 98, 1848–1852.
Bellamy, MF, McDowell, IF, Ramsey, MW, Brownlee, M, Newcombe, RG & Lewis, MJ (1999) Oral folate enhances endothelial function in hyperhomocysteinaemic subjects. European Journal of Clinical Investigation 29, 659–662.
Böger, RH, Bode-Böger, SM, Sydow, K, Heistad, DD & Lentz, SR (2000 a) Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocysteinemia or hypercholesterolemia. Arteriosclerosis Thrombosis and Vascular Biology 20, 1557–1564.
Böger, RH, Bode-Böger, SM, Szuba, A, Tsao, PS, Chan, JR, Tangphao, O, Blaschke, TF & Cooke, JP (1998) Asymmetric dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction. Its role in hypercholesterolemia. Circulation 98, 1842–1847.
Böger, RH, Bode-Böger, SM, Tsao, PS, Lin, PS, Chan, JR & Cooke, JP (2000 b) An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes. Journal of the American College of Cardiology 36, 2287–2295.
Böger, RH, Lentz, SR, Bode-Böger, SM, Knapp, HR & Haynes, WG (2001) Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocysteinemia in humans. Clinical Science 100, 161–167.
Boushey, CJ, Beresford, SA, Omenn, GS & Motulsky, AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. Journal of the American Medical Association 274, 1049–1057.
Brattstrom, LE, Israelsson, B, Jeppsson, JO & Hultberg, BL (1988) Folic acid – an innocuous means to reduce plasma homocysteine. Scandinavian Journal of Clinical and Laboratory Investigation 48, 215–221.
Chambers, JC, McGregor, A, Jean-Marie, J & Kooner, JS (1998) Acute hyperhomocysteinemia and endothelial dysfunction. Lancet 351, 36–37.
Department of Health and Human Services (1993) Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Washington, DC: Department of Health and Human Services.
Feng, Q, Lu, X, Fortin, AJ, Pettersson, A, Hedner, T, Kline, RL & Arnold, JMO (1998) Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure. Cardiovascular Research 37, 667–675.
Furchgott, RF & Zawadzki, JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288, 373–376.
Harker, LA, Slichter, SJ, Scott, CR & Ross, R (1974) Homocystinemia, vascular injury and arterial thrombosis. New England Journal of Medicine 291, 537–543.
Holven, KB, Holm, T, Aukrust, P, Christensen, B, Kjekshus, J, Andreassen, AK, Gullestad, L, Hagve, TA, Svilaas, A, Ose, L & Nenseter, MS (2001) Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects. American Journal of Medicine 110, 536–542.
Kokame, K, Kato, H & Miyata, T (1996) Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. GRP7/iP and novel genes. Journal of Biological Chemistry 271, 29659–29665.
Lentz, SR, Sobey, CG, Piegors, DJ, Bhopatkar, MY, Faraci, FMM, Malinow, R & Heistad, DD (1996) Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. Journal of Clinical Investigation 98, 24–29.
Matsuoka, H, Itoh, S, Kimoto, M, Kohno, K, Tamai, O, Wada, Y, Yasukawa, H, Iwami, G, Okuda, S & Imaizumi, T (1997) Asymmetrical dimethylarginine, an endogenous inhibitor, in experimental hypertension. Hypertension 29, 242–247.
Miyazaki, H, Matsuoka, H, Cooke, JP, Usui, M, Ueda, S, Okuda, S & Imaizumi, T (1991) Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation 99, 1141–1146.
Stuhlinger, MC, Tsao, PS, Her, JH, Kimoto, M, Balint, RF & Cooke, JP (2001) Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation 104, 2569–2575.
Tawakol, A, Omland, T, Gerhard, M, Wu, JT & Creager, MA (1997) Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 95, 1119–1121.
Ubbink, JB, Vermaak, WJH & Bissbort, S (1991) Rapid high-performance liquid chromatography assay for total homocysteine levels in human serum. Journal of Chromatography 565, 441–446.
Ueland, PM, Refsum, H & Brattstrøm, L (1992) Plasma homocysteine and cardiovascular disease. In Atherosclerotic Cardiovascular Disease, Hemostasis, and Endothelial Function, pp. 182 –222 [Francis, RBJ, editor]. New York: Marcel Dekker.
Upchurch, GR Jr, Welch, GN, Fabian, AJ, Freedman, JE, Johnson, JL, Keaney, JF Jr & Loscalzo, J (1997) Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. Journal of Biological Chemistry 272, 17012–17017.
Usui, M, Matsuoka, H, Miyazaki, H, Ueda, S, Okuda, S & Imaizumi, T (1999) Endothelial dysfunction by acute hyperhomocysteinemia: restoration by folic acid. Clinical Science 96, 235–239.
Wang, H, Yoshizumi, M, Lai, K, Tsai, JC, Perrella, MA, Haber, E & Lee, ME (1997) Inhibition of growth and p21ras methylation in vascular endothelial cells by homocysteine but not cysteine. Journal of Biological Chemistry 272, 25380–25385.
Wilmink, W, Stroes, ESG, Erkelens, WD, Gerritsen, WB, Wever, R, Banga, J-D & Rabelink, TJ (2000) Influence of folic acid on postprandial endothelial dysfunction. Arteriosclerosis Thrombosis and Vascular Biology 20, 185–188.
Woo, KS, Chook, P, Lolin, YI, Cheung, ASP, Chan, LT, Sun, YY, Sanderson, JE, Metreweli, C & Celermajer, DS (1997) Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. Circulation 96, 2542–2544.
Woo, KS, Chook, P, Lolin, YI, Sanderson, JE, Metreweli, C & Celermajer, DS (1999) Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. Journal of American College of Cardiology 34, 2002–2006.
Yoo, J-H & Lee, S-C (2001) Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke. Atherosclerosis 158, 425–430.